Home > Products > FGF2 & VEGF
> Recombinant Anti-FGF2 x Anti-VEGF Bispecific Antibody (Triple Body)
Recombinant Anti-FGF2 x Anti-VEGF Bispecific Antibody (Triple Body) (CAT#: TRIB-160)
Recombinant Anti-FGF2 x Anti-VEGF Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-FGF2 antibody are both extended with the scFv fragment from an anti-VEGF antibody. This BsAb can bind and inactivate two ligands simultaneously. It is designed for the research of Hepatocellular cancer (HCC); Breast cancer; Colon cancer; Lung cancer; Glioma cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-FGF2 x Anti-VEGF Bispecific Antibody (Triple Body) (TRIB-160). Click the button below to contact us or submit your feedback about this product.